The company's P53Diicbiome innovation allows early detection of people at risk of cancer-related complications.
FEMTO Research Group Co., Ltd. Service Innovation in Thailand at the 2025 Healthcare Asia Awards for its pioneering work in cancer testing and COVID-19 and COVID-19 and genome research.
Emerging research shows that cancer patients are susceptible to severe Covid-19 results three times as much as severe Covid-19 results because the immune system has been compromised. In addition, recent findings suggest that the SARS-COV-2 virus may be integrated into the human genome, potentially leading to the development of new cancers or worsening existing diseases.
The FEMTO research team has been at the forefront of this discovery. During the Covid-19 pandemic, the company's researchers found that 23% of the patients tested had viral genome integration.
At the heart of the success of the FEMTO research group is its p53microbiome and p53diicbiome Technologies, which have won the Healthcare Asia Service Innovation Award for seven consecutive years from 2018 to 2024.
These innovations use DNA extracted from dry saliva, noninvasively on cotton pads at home, and shipped to FEMTO labs for analysis. This method allows early detection of genomic infections associated with cancer, providing convenient and convenient solutions for at-risk individuals.
Using the P53Diicbiome 2025 innovation, patients with SARS-COV-2 virus integration can be identified before symptoms appear. This will enable healthcare providers to manage, mitigate or prevent severe cancer-related complications. Meanwhile, those who have been diagnosed with cancer can get more personalized treatment plans based on their genome profile.
By understanding viral genome integration, doctors can also better predict relapses, complications, and disease progression.
As it continues to develop groundbreaking solutions, FEMTO Research Group Co., Ltd. The future of cancer diagnosis, patient care and medical innovation is being shaped.
The Asian Healthcare Awards redefines hospitals of excellence in the region through its innovative solutions and substantial contributions to the community that redefine the industry’s standards of excellence.
The Asian Healthcare Award is presented by Healthcare Asia Magazine. To view the full list of winners, click here. If you want to join the 2026 Awards Ceremony and are praised for your organization's outstanding initiatives and contributions to the healthcare industry, please contact JulieAnne Nuñez [email protected].
